Advanced Cell Technology to Announce Third Quarter Financial Results on Thursday, November 8th

Company to Hold Conference Call at 4:30 p.m. Eastern Time

Advanced Cell Technology to Announce Third Quarter Financial Results on Thursday, November 8

Investors:CEOcast, Inc.James Young, 212-732-4300orPress:ACT Corporate CommunicationsBill Douglass, 646-450-3615orRusso PartnersMartina Schwarzkopf, Ph.D., 212-845-4292

Advanced Cell Technology, Inc. (“ACT”, OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine announced today that it will release its third quarter 2012 financial results on Thursday, November 8 after the market closes. The Company will hold a conference call at 4:30 p.m. EST that day during which it will discuss its results and provide a corporate update.

Interested parties may dial (888) 264-3177 or 706-902-4345 using reference conference ID number 90962762. The call will be available live and for replay by webcast at: .

Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit .

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.